Midluteal matrix metalloproteinase and tissue-inhibiting metalloproteinase plasma levels after embryo transfer

Maher A Abdallah; Steven T Nakajima; Abby C Eblen; Alberto Carrillo; Cicek Gercel-Taylor

doi:10.1016/j.fertnstert.2004.03.045

Midluteal matrix metalloproteinase and tissue-inhibiting metalloproteinase plasma levels after embryo transfer

Fertil Steril. 2004 Oct;82(4):966-7. doi: 10.1016/j.fertnstert.2004.03.045.

Authors

Maher A Abdallah¹, Steven T Nakajima, Abby C Eblen, Alberto Carrillo, Cicek Gercel-Taylor

Affiliation

¹ Department of Obstetrics, Gynecology, and Women's Health, University of Louisville, Louisville, Kentucky 40292, USA. maherabdallah@aol.com

PMID: 15482783
DOI: 10.1016/j.fertnstert.2004.03.045

Abstract

This study demonstrates significant differences in the midluteal concentrations of active matrix metalloproteinase (MMP)-1, MMP-2, and total MMP-3 between patients who conceived and those who did not after day 3 ET.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Embryo Implantation / physiology*
Embryo Transfer*
Estrogens / blood
Female
Fertilization in Vitro
Humans
Luteal Phase / physiology
Male
Matrix Metalloproteinases / blood*
Pilot Projects
Pregnancy
Progesterone / blood
Prospective Studies
Tissue Inhibitor of Metalloproteinases / blood*

Substances

Estrogens
Tissue Inhibitor of Metalloproteinases
Progesterone
Matrix Metalloproteinases